ConductScience.org, home

Gene · 4350

Papers2,085

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

321 to 340 of 2,085

Download this page as JSON
TitleJournalYearPMIDFound bySource
KDM6B promotes PARthanatos via suppression of O6-methylguanine DNA methyltransferase repair and sustained checkpoint response.Nucleic Acids Res202235648484PubTator, text miningPubMed
Association between forkhead box P3 expression level and gender of Iranian juvenile idiopathic arthritis patients.Reumatologia202235645413PubTator, text miningPubMed
Nipple aspirate fluid and its use for the early detection of breast cancer.Ann Med Surg (Lond)202235638006PubTator, text miningPubMed
Polymorphic Phase Transformations in Nanocrystalline Ag2S Silver Sulfide in a Wide Temperature Interval and Influence of Nanostructured Ag2S on the Interface Formation in Ag2S/ZnS Heteronanostructure.Nanomaterials (Basel)202235630889PubTator, text miningPubMed
The Role of DNA Repair in Genomic Instability of Multiple Myeloma.Int J Mol Sci202235628498PubTator, text miningPubMed
Alterations in Molecular Profiles Affecting Glioblastoma Resistance to Radiochemotherapy: Where Does the Good Go?Cancers (Basel)202235626024PubTator, text miningPubMed
The Roles and Regulation of m6A Modification in Glioblastoma Stem Cells and Tumorigenesis.Biomedicines202235625706PubTator, text miningPubMed
Tumor microenvironment responsive Mn3O4 nanoplatform for in vivo real-time monitoring of drug resistance and photothermal/chemodynamic synergistic therapy of gastric cancer.J Nanobiotechnology202235606848PubTator, text miningPubMed
Construction and validation of a novel apoptosis-associated prognostic signature related to osteosarcoma metastasis and immune infiltration.Transl Oncol202235598382PubTator, text miningPubMed
Computational investigations on target-site searching and recognition mechanisms by thymine DNA glycosylase during DNA repair process.Acta Biochim Biophys Sin (Shanghai)202235593467PubTator, text miningPubMed
Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life.Clin Mol Allergy202235590407PubTator, text miningPubMed
Discovery of METTL3 Small Molecule Inhibitors by Virtual Screening of Natural Products.Front Pharmacol202235571106PubTator, text miningPubMed
Identification of microRNA-mRNA regulatory network associated with oxidative DNA damage in human astrocytes.ASN Neuro202235570825PubTator, text miningPubMed
Lactoferrin as a Human Genome "Guardian"-An Overall Point of View.Int J Mol Sci202235563638PubTator, text miningPubMed
Printer center nanoparticles alter the DNA repair capacity of human bronchial airway epithelial cells.NanoImpact202235559885PubTator, text miningPubMed
Temporal Dynamics of the Nasopharyngeal Microbiome and its Relationship with Childhood Asthma Exacerbation.Microbiol Spectr202235546575PubTator, text miningPubMed
Trovafloxacin drives inflammation-associated drug-induced adverse hepatic reaction by changing macrophage polarization.Toxicol In Vitro202235537566PubTator, text miningPubMed
Xeroderma Pigmentosum Complementation Group C (XPC): Emerging Roles in Non-Dermatologic Malignancies.Front Oncol202235530314PubTator, text miningPubMed
A multiplex platform for small RNA sequencing elucidates multifaceted tRNA stress response and translational regulation.Nat Commun202235513407PubTator, text miningPubMed
Contribution of portable obstetric ultrasound service innovation in averting maternal and neonatal morbidities and mortalities at semi-urban health centers of Ethiopia: a retrospective facility-based study.
BMC Pregnancy Childbirth202235484533PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/4350/papers?page=17